Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moingeon

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Allergy and Clinical Immunology|April 3, 2012
A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapyAline Zimmer, Julien Bouley, Maxime Le Mignon, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2016
Circulating innate lymphoid cells are differentially regulated in allergic and nonallergic subjectsVincent Lombardi, Chloé Beuraud, Catherine Neukirch, et al.
Expert Opinion on Drug Discovery|July 5, 2022
Industrializing AI-powered drug discovery: lessons learned from the <i>Patrimony</i> computing platformMickaël Guedj, Jack Swindle, Antoine Hamon, et al.
Plos One|July 22, 2021
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19Emiko Desvaux, Antoine Hamon, Sandra Hubert, et al.
Journal of Autoimmunity|December 19, 2023
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndromeEmiko Desvaux, Patrice Hemon, Perrine Soret, et al.
Journal of Translational Autoimmunity|March 22, 2021
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseasesFanny Duguet, Céline Ortega-Ferreira, Benjamin Fould, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|March 31, 2007
Validation of quantitative, allergen-specific ELISAsWolf-Meinhard Becker, Ronald van Ree, Helmut Fiebig, et al.
Plos One|June 24, 2025
Genetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohortMieke L M Bentvelzen, Paco M J Welsing, Philippe Moingeon, et al.
International Archives of Allergy and Immunology|June 3, 2006
Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccinesThierry Batard, Alexandre Hrabina, Xue Zhi Bi, et al.
Iscience|February 10, 2025
Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupusVincent Hurez, Glenn Gauderat, Perrine Soret, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Allergy and Clinical Immunology|April 3, 2012
A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapyAline Zimmer, Julien Bouley, Maxime Le Mignon, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2016
Circulating innate lymphoid cells are differentially regulated in allergic and nonallergic subjectsVincent Lombardi, Chloé Beuraud, Catherine Neukirch, et al.
Expert Opinion on Drug Discovery|July 5, 2022
Industrializing AI-powered drug discovery: lessons learned from the <i>Patrimony</i> computing platformMickaël Guedj, Jack Swindle, Antoine Hamon, et al.
Plos One|July 22, 2021
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19Emiko Desvaux, Antoine Hamon, Sandra Hubert, et al.
Journal of Autoimmunity|December 19, 2023
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndromeEmiko Desvaux, Patrice Hemon, Perrine Soret, et al.
Journal of Translational Autoimmunity|March 22, 2021
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseasesFanny Duguet, Céline Ortega-Ferreira, Benjamin Fould, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|March 31, 2007
Validation of quantitative, allergen-specific ELISAsWolf-Meinhard Becker, Ronald van Ree, Helmut Fiebig, et al.
Plos One|June 24, 2025
Genetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohortMieke L M Bentvelzen, Paco M J Welsing, Philippe Moingeon, et al.
International Archives of Allergy and Immunology|June 3, 2006
Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccinesThierry Batard, Alexandre Hrabina, Xue Zhi Bi, et al.
Iscience|February 10, 2025
Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupusVincent Hurez, Glenn Gauderat, Perrine Soret, et al.
Pageof 12